Health Care [ 10/12 ] | Biotechnology [ 38/73 ]
NASDAQ | Common Stock
bioAffinity Technologies, Inc. engages in developing non-invasive diagnostics to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis in the United States.
It operates through two segments: Diagnostic Research and Development; and Laboratory Services.
The company offers CyPath lung which uses flow cytometry technology to detect and analyze cell populations in a person's sputum, or phlegm, to find characteristics indicative of lung cancer, including cancer and/or cancer-related cells that have shed from a lung tumor. bioAffinity Technologies, Inc. was incorporated in 2014 and is based in San Antonio, Texas.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Aug 14, 25 | -0.17 Increased by +10.53% | -0.10 Decreased by -70.00% |
| May 20, 25 | -0.19 Increased by +25.79% | -0.17 Decreased by -12.06% |
| Mar 31, 25 | -0.19 Decreased by N/A% | -0.14 Decreased by -35.71% |
| Nov 14, 24 | -0.16 Increased by +38.46% | -0.15 Decreased by -6.67% |
| Aug 14, 24 | -0.19 Increased by +5.00% | -0.17 Decreased by -11.76% |
| May 15, 24 | -0.26 Decreased by -42.61% | -0.20 Decreased by -28.35% |
| Mar 5, 24 | 0.00 Increased by +100.00% | -0.20 Increased by +100.00% |
| Nov 14, 23 | -0.26 Increased by +77.78% | -0.15 Decreased by -73.33% |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Jun 30, 25 | 1.27 M Decreased by -47.06% | -4.06 M Decreased by -92.45% | Decreased by -319.88% Decreased by -263.54% |
| Mar 31, 25 | 1.85 M Decreased by -22.94% | -2.66 M Decreased by -35.58% | Decreased by -143.47% Decreased by -75.94% |
| Dec 31, 24 | 2.21 M Decreased by -0.24% | -2.97 M Decreased by -25.02% | Decreased by -134.38% Decreased by -25.33% |
| Sep 30, 24 | 2.35 M Increased by +687.31% | -2.00 M Increased by +12.65% | Decreased by -85.15% Increased by +88.91% |
| Jun 30, 24 | 2.40 M Increased by +12.05 K% | -2.11 M Decreased by -21.25% | Decreased by -87.99% Increased by +99.00% |
| Mar 31, 24 | 2.41 M Increased by +261.14 K% | -1.96 M Decreased by -28.00% | Decreased by -81.55% Increased by +99.95% |
| Dec 31, 23 | 2.21 M Increased by +94.25 K% | -2.37 M Decreased by -41.72% | Decreased by -107.22% Increased by +99.85% |
| Sep 30, 23 | 298.48 K Increased by +25.86 K% | -2.29 M Increased by +53.43% | Decreased by -767.51% Increased by +99.82% |